These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22095123)

  • 1. Tris-2(hydroxyethyl) ammonium 2-methylphenoxyacetate as an inhibitor of synthesis of liver phospholipase A1.
    Bobkova SN; Rasulov MM; Nurbekov MK; Belikova OA; Shimanovskaya NP; Voronkov MG
    Dokl Biochem Biophys; 2011; 440():219-20. PubMed ID: 22095123
    [No Abstract]   [Full Text] [Related]  

  • 2. Tris-2(hydroxyethyl) ammonium 2-methylphenoxyacetate as an activator of aorta intima acid lipase.
    Voronkov MG; Bobkova SN; Rasulov MM; Nurbekov MK; Belikova OA
    Dokl Biochem Biophys; 2011; 440():211-2. PubMed ID: 22095120
    [No Abstract]   [Full Text] [Related]  

  • 3. Tris-2(hydroxyethyl)ammonium (2-methylphenoxy)acetate as an inhibitor of synthesis of acid phospholipase A2 of mononuclear cells.
    Rasulov MM; Bobkova SN; Belikova OA; Nurbekov MK; Voronkov MG
    Dokl Biochem Biophys; 2012; 444():137-9. PubMed ID: 22772994
    [No Abstract]   [Full Text] [Related]  

  • 4. Tris-2(hydroxyethyl)ammonium (2-methylphenoxy)acetate as an inhibitor of synthesis of acid cholesterol esterase of platelets and mononuclear cells.
    Rasulov MM; Bobkova SN; Belikova OA; Nurbekov MK; Shimanovskaya NP; Voronkov MG
    Dokl Biochem Biophys; 2011; 441():270-2. PubMed ID: 22218952
    [No Abstract]   [Full Text] [Related]  

  • 5. Tris-2(hydroxyethyl)ammonium 2-methylphenoxyacetate activates the synthesis of mRNA aminoacyl-tRNA synthetase.
    Nurbekov MK; Rasulov MM; Voronkov MG; Bobkova SN; Belikova OA
    Dokl Biochem Biophys; 2011; 438():131-3. PubMed ID: 21725890
    [No Abstract]   [Full Text] [Related]  

  • 6. The complex of zinc bis-(2-methylphenoxyacetate) with tris-2(hydroxyethyl) amine as an activator of synthesis of total tryptophanyl-tRNA synthetase.
    Rasulov MM; Voronkov MG; Nurbekov MK; Zvereva MV; Mirskova AN; Adamovich SN; Mirskov RG
    Dokl Biochem Biophys; 2012; 444():147-8. PubMed ID: 22772997
    [No Abstract]   [Full Text] [Related]  

  • 7. Tris-(2-hydroxyethyl)ammonium 2-methyl- and 2-methyl-4-chlorophenoxyacetate serve as effective inhibitors of thrombocyte aggregation and antioxidants.
    Mirskova AN; Adamovich SN; Mirskov RG; Voronkov MG
    Dokl Biol Sci; 2010; 433():244-6. PubMed ID: 20711867
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of phospholipase A1, lipase and galactolipase activities of pancreatic lipase-related protein 2 by methyl arachidonyl fluorophosphonate (MAFP).
    Amara S; Delorme V; Record M; Carrière F
    Biochim Biophys Acta; 2012 Nov; 1821(11):1379-85. PubMed ID: 22835523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase.
    Inloes JM; Hsu KL; Dix MM; Viader A; Masuda K; Takei T; Wood MR; Cravatt BF
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14924-9. PubMed ID: 25267624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of trecresanum to stimulate antibody formation in offspring of experimental animals during the embryonic period.
    Pavel UG; Karus AL; Kumar JA; Schattschneider TK; Voronkov MG
    Dokl Biol Sci; 2002; 385():323-5. PubMed ID: 12469603
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effect of ammonium ions and L-norvaline on galactosamine induced liver injury.
    Pausch J; Wohleb B; Gerok W
    Hoppe Seylers Z Physiol Chem; 1977 May; 358(5):595-7. PubMed ID: 881166
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
    Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
    Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in triton WR-1339-induced hyperlipidemia.
    Kuroda M; Tanzawa K; Tsujita Y; Endo A
    Biochim Biophys Acta; 1977 Oct; 489(1):119-25. PubMed ID: 911870
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydrolysis of low-density lipoprotein phospholipids in arterial smooth muscle cells.
    Ishikawa Y; Nishide T; Sasaki N; Shirai K; Saito Y; Yoshida S
    Biochim Biophys Acta; 1988 Jul; 961(2):170-6. PubMed ID: 3390454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of cholesteryl ester-enriched very low density lipoproteins by the liver of cholesterol-fed rabbits.
    MacKinnon AM; Savage J; Gibson RA; Barter PJ
    Atherosclerosis; 1985 Feb; 54(2):145-55. PubMed ID: 3986014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.
    Shiomi M; Yamada S; Amano Y; Nishimoto T; Ito T
    Br J Pharmacol; 2008 Jul; 154(5):949-57. PubMed ID: 18587443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the liver in the degradation of lipoproteins.
    Cooper AD
    Gastroenterology; 1985 Jan; 88(1 Pt 1):192-205. PubMed ID: 2981081
    [No Abstract]   [Full Text] [Related]  

  • 19. Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed mice.
    Castellanos-Tapia L; Tejero-Barrera ME; Salas-Silva S; Simoni-Nieves A; Escobedo-Calvario A; Gomez-Quiroz LE
    Ann Hepatol; 2020; 19(5):489-496. PubMed ID: 32663612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice.
    Hoekstra M; Nahon JE; de Jong LM; Kröner MJ; de Leeuw LR; Van Eck M
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1402-1409. PubMed ID: 30776415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.